Recent Security Class Actions

CVRx Inc. Common Stock (NASDAQ: CVRX)

52 Days left to seek lead plaintiff status.

Company Name:CVRx Inc. Common Stock
Stock Symbol:NASDAQ: CVRX
Class Period Start:07/25/2023
Class Period End (inclusive):08/06/2026
Filing Deadline:01/08/2027

The complaint alleges Defendants made false and/or misleading statements and/or failed to disclose that: (a) to induce sales growth, CVRx and/or its employees were engaged in illegal and unsustainable sales practices, including improperly marketing Barostim, offering or paying kickbacks, and providing false information to government health insurance programs in violation of the False Claims Act (“FCA”) and Anti-Kickback Statute (“AKS”); (b) CVRx’s revenues were in part the product of such unlawful conduct and thus unsustainable; (c) the illegal sales and marketing activities increased the risk of criminal and civil liability; and (d) as a result of the foregoing, Defendants’ public statements, including the Company’s reported revenue, purported growth drivers, compliance with the FCA and AKS, the effectiveness of its patient access and reimbursement strategy, and the effectiveness of CVRx’s internal controls over financial reporting were materially false and misleading at all relevant times.  
 
Additionally, throughout the Class Period, Defendants made materially false and misleading statements regarding the progress of the Company’s sales force realignment and the transformation of its commercial organization. Specifically, the Defendants made false and/or misleading statements and/or failed to disclose that: (a) contrary to Defendants’ assurances, sales force turnover had not been stabilized and productivity remained materially below expectations because the sales organization required additional training, support, and restructuring; (b) a significant portion of the sales force was inexperienced, required extended training and ramp time, and were not yet capable of generating the productivity to meet revenue projections; and (c) that as a result of the foregoing, Defendants’ public statements regarding the progress of the Company’s sales force realignment and the transformation of its commercial organization were materially false and misleading at all relevant times.

CVRx Inc. Common Stock (NASDAQ: CVRX) Claim Form

This field is for validation purposes and should be left unchanged.
Name(Required)
Address